Cell-free Assays (IC50/Ki) for AZD5363 (Capivasertib)

Key TargetIC50 (Cell-free)DescriptionReference
AKT1, AKT2, AKT3 AKT1 (3 nmol/L), AKT2 (9 nmol/L), AKT3 (3 nmol/L) ATP-competitive pan-AKT inhibitor potency measurement Download PDF
AKT 1, AKT 2, AKT 3 < 10 nM Enzyme inhibition assay Download PDF

Cell-based Assay (IC50) for AZD5363 (Capivasertib)

Cell TypeIC50 (Cell-based)DescriptionReference
MCF7 3nM MTT method Download PDF
971 cancer cell lines < 9 µM 72 hour proliferation assays Download PDF
JRT3T35 0.27 µM Acumen Explorer based sytox green assay Download PDF
CCRF-CEM 0.3 µM Acumen Explorer based sytox green assay Download PDF
MOLT4 0.28 µM Acumen Explorer based sytox green assay Download PDF
Check the AZD5363 (Capivasertib) product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.

Jump to